Gritstone bio Inc. - GRTS Net earnings per share for the last four quarters

Official company branding of Gritstone Bio (GRTS)

The immediate triggers for Gritstone bio, Inc. (GRTS) are linked to the publication of personalized vaccine test results. Gritstone bio, Inc. (GRTS) is expanding its portfolio by applying its platforms to oncology and infectious disease therapies. Demand for such developments remains independent of macroeconomics and GDP cycles. The 12-month YoY EPS trend visualizes profit dynamics, where 10.60 represents the latest metric reading.

Gritstone bio (GRTS) Earnings per share for the last twelve months: for the period 02/11/2024 - 02/20/2024

GRTS (Gritstone bio Inc.): analytical breakdowns and indicator data

Initial company analysis:GRTS, Gritstone bio, Inc.
Mass-produced product of Gritstone bio

The dynamics of this indicator depend directly on the difference between operating revenues and total expenses. This metric measures the percentage change in net income per share over a rolling year, reflecting the business's scaling pace. For Gritstone bio, Inc. (GRTS), the absence of proprietary manufacturing plants minimizes capital expenditures, making profit sensitive to outsourcing costs. By analyzing the EPS YoY TTM growth value, an investor determines the efficiency of external contract management.

Direct competitors

Earnings per share for the trailing year IBRX (ImmunityBio)|IMCR: Net earnings per share (EPS TTM)|JANX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months arcusbio.com|Net earnings per share for the last 12 months zymeworks.com (ZYME)|Earnings per share for the last twelve months Tango Therapeutics Inc (TNGX)|Net earnings per share for the last 12 months Iovance IOVA|Immatics NV - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Xencor Inc. XNCR|CMPX - Earnings per share for the last twelve months|REPL (replimune.com) - Earnings per share for the last 12 months|Lyell Pharma (LYEL) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Innate Pharma, S.A. (IPHA)|Net earnings per share for the last 12 months PYXS|CGEN - Net earnings per share for the trailing year|Net earnings per share for the last 12 months IOBT (IO Biotech Corp)|Earnings per share for the last four quarters STRO|Net earnings per share (EPS TTM) INKT (MiNK Therapeutics)|Earnings per share for the trailing year HOWL|Immix - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ALX Oncology Holdings Inc.|CUE: Net earnings per share (EPS TTM)|PDS Biotech - Earnings per share for the trailing year|SONN (Sonnet BioTherapeutics Holdings Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) MAIA Biotech|Earnings per share for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Earnings per one share for the last 12 months|NextCure Inc - Net earnings per share for the last 12 months|Leap Therapeutics, Inc. (LPTX) - Net earnings per one share for the last twelve months|Intensity Therapeutics Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters senseibio.com SNSE|TOVX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Kineta, Inc. (KA)|Net earnings per share for the last 12 months NEXI|TSBX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) VCNX|HARP: Earnings per one share for the last 12 months